Sanofi announced the inauguration of the Charles Best Building in Toronto, Canada, to support production of the firm’s ...

The collaboration seeks to bring affordable cancer treatments to the region while advancing the ambitious Saudi Vision 2030.

Boost mAb purification efficiency by replacing bind-and-elute CEX with flow-through HIC, achieving higher loadings and ...

An industry paper argues that the first company to make quality-acceptable extended reality (XR) records will own the market.

Samsung Biologics secures $262m manufacturing deal with European pharma as it expands Bio Campus II at Songdo to 720 kL by ...

AI tools are reshaping drug development and manufacturing, but their effectiveness depends on robust data and human ...

The company was selected for the country’s Industrialization and Health Capacities 2030 program earlier this year.

Phacilitate Advanced Therapies Europe 2026 tackled cell and gene therapy commercialization barriers as stakeholders work to ...

Biopharma leaders soon will learn to partner with wearable AI systems to facilitate communication and decision-making in ...

Next-gen AAV manufacturing can enable scalable, affordable gene therapies through producer cell lines, process ...

CAR T therapies face scalability challenges. An eXmoor consultant explores how synthetic approaches using lipid nanoparticles ...

Large pharmaceutical firm Novartis confirmed that it is halting and investigating several clinical trial programs involving its chimeric antigen receptor (CAR) T-cell therapy rapcabtagene autoleucel ...